Medidata Study Experience

  1. Using Data To Accelerate Racial Diversity In US Clinical Trials 11/2/2022

    Historically, US clinical trials have been shown to recruit disproportionately large percentages of White patients, raising concerns about the generalizability of clinical trial results to underrepresented racial minority patient populations. Because of this, the FDA has recently reiterated its guidance stating that clinical trials need to reflect the demographic distribution of the US. 

  2. Data-Powered Financial Management For Your Clinical Trials 10/20/2022

    Achieve complete financial visibility, eliminate complexity, and ensure the financial health of your clinical trials with Rave Clinical Trial Financial Management.

  3. Improving Diversity In Clinical Trials 10/17/2022

    Watch how building on your existing feasibility processes and selecting countries and sites that can not only help you accelerate your study, but also increase diversity. 

  4. Reducing Uncertainty: AI & Data Can Help Fuel New Ways Of Working On Clinical Trials & Beyond 10/6/2022

    In this podcast, explore how artificial intelligence and data can help fuel new ways of working on clinical trials and beyond, and the benefits are clear in the heavily regulated industry.

  5. Predictors Of Severe CRS In Longitudinal CAR T-Cell Clinical Trial Data 9/15/2022

    Find out how laboratory tests were analyzed with repeated measurements to identify differences in trends that persist across a variety of study designs, sponsors, and indications.

  6. Solving The Impossible In Glioblastoma With An AI Synthetic Control Arm 9/9/2022

    This video discusses Medicenna’s MDNA55-05 clinical trial; a single-arm, open-label, multicenter study that offers a promising opportunity to improve outcomes for recurrent glioblastoma.

  7. Patient-Level Clinical Trial Data + Real World Data 9/6/2022

    Future-proof your clinical trial and enhance your evidence generation activities with Medidata Link, which allows sponsors to collect clinical trial data and link it at the patient level to real-world data (RWD).

  8. The Next Generation Of Clinical Trial Data Management Software 9/6/2022

    Find out how the linking of clinical and real-world data (RWD) lets sponsors power the next generation of clinical development and accelerate evidence generation activities.

  9. How Data Impacts GBM/RGB Clinical Trials? 8/25/2022

    In this video, Elizabeth Lamont, Senior Medical Director for Medidata AI, describes how an external control arm can be used in rGBM/GBM and the advantages of using an AI SCA, built upon historical clinical trial data.

  10. Insights Into Clinical Trial Enrollment 5/18/2022

    Explore the continued impact of the pandemic on clinical trial enrollment in Phase II and III studies to help the industry navigate the dynamic landscape in 2022 across four therapeutic areas (TAs).